Back
ESC Premium Access

Association of renin-angiotensin system inhibition with clinical outcomes in patients undergoing transcatheter aortic valve replacement: analysis from the STS/ACC TVT Registry

Session: Outcome prediction tools after valve intervention
Topic: Pharmacotherapy
Speaker: Doctor T. Inohara (Tokyo, JP)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Taku Inohara

Keio University School of Medicine, Tokyo (Japan)
0 follower

6 more presentations in this session

Impact of elixhauser comorbidity score on the outcomes of transcatheter aortic valve replacement

Speaker: Doctor V. Nagaraja (Rochester, US)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and prognostic impact of prosthesis-patient mismatch after transcatheter aortic valve implantation

Speaker: Doctor N. Schofer (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Temporal trends on percutaneous mitral commissurotomy: 30 years of experience

Speaker: Doctor C. Desnos (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Development of immediate and late predictor score of success after percutaneous mitral valvoplasty in patients with mitral stenosis

Speaker: Doctor J. Costa Jr (Sao Paulo, BR)

Access
Slides
Like
Thumbnail

Prognostic value of logistic EuroSCORE and STS-PROM in a recent patient cohort undergoing TAVI with next generation transcatheter heart valves

Speaker: Mr B. Al-Kassou (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Outcome prediction tools after valve intervention

Speakers: Doctor T. Inohara, Doctor V. Nagaraja, Doctor N. Schofer, Doctor C. Desnos, Doctor J. Costa Jr...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources